Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma.
Int J Mol Sci. 2023 Jan 2;24(1):799. doi: 10.3390/ijms24010799.
Int J Mol Sci. 2023.
PMID: 36614241
Free PMC article.
Review.
Impact of ABC Transporters in Osteosarcoma and Ewing's Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?
Serra M, Hattinger CM, Pasello M, Casotti C, Fantoni L, Riganti C, Manara MC.
Serra M, et al. Among authors: fantoni l.
Cells. 2021 Sep 17;10(9):2461. doi: 10.3390/cells10092461.
Cells. 2021.
PMID: 34572110
Free PMC article.
Review.
Item in Clipboard
Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies.
Hattinger CM, Patrizio MP, Fantoni L, Casotti C, Riganti C, Serra M.
Hattinger CM, et al. Among authors: fantoni l.
Cancers (Basel). 2021 Jun 9;13(12):2878. doi: 10.3390/cancers13122878.
Cancers (Basel). 2021.
PMID: 34207685
Free PMC article.
Review.
Item in Clipboard
Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing.
Hattinger CM, Casotti C, Patrizio MP, Luppi S, Fantoni L, Scotlandi K, Ibrahim T, Serra M.
Hattinger CM, et al. Among authors: fantoni l.
Int J Mol Sci. 2022 Oct 4;23(19):11787. doi: 10.3390/ijms231911787.
Int J Mol Sci. 2022.
PMID: 36233089
Free PMC article.
Item in Clipboard
Single-nucleotide polymorphism profiling by multimodal-targeted next-generation sequencing in methotrexate-resistant and -sensitive human osteosarcoma cell lines.
Casotti C, Hattinger CM, Patrizio MP, Luppi S, Fantoni L, Pasello M, Scotlandi K, Ibrahim T, Serra M.
Casotti C, et al. Among authors: fantoni l.
Front Pharmacol. 2023 Nov 22;14:1294873. doi: 10.3389/fphar.2023.1294873. eCollection 2023.
Front Pharmacol. 2023.
PMID: 38074116
Free PMC article.
Item in Clipboard
Cite
Cite